Early access
Sign in
Taking people in United StatesNo phase

Behavioral Intervention for Youth to Promote Vaping Cessation

Key facts

Who runs it
Massachusetts General Hospital
Where
Boston, United StatesSee the site
Trial code
Status
Recruiting
People taking part
400 people, planned
Started
18 Jun 2025
Expected to end
31 Aug 2029
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • QuitVaping
  • This is Quitting (TIQ)
Record updated
7 July 2026

Who can take part

Age
14 years to 19 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 11 criteriaShow less

Who can take part

  • Age 14-19 inclusive
  • Self-report of at least weekly nicotine vaping (or use of other non combusted nicotine products, "vaping") for the prior ≥3 months
  • Self-report of no regular combusted tobacco use (i.e., 5 or more days of smoke smoked tobacco use per week) prior to enrollment and exhaled CO <10 ppm for those with an in person baseline visit
  • Report willingness to try to quit or reduce vaping in the next 30 days
  • Able to understand study procedures and read and write in English or Spanish
  • Have a parent or legal guardian who is able to participate in the opt out process
  • Competent and willing to provide written informed consent (if age 18) or assent (if under 18)

Who cannot take part

  • Use of a smoking cessation medication in the prior month (nicotine patch, gum, nasal spray, or inhaler, varenicline, bupropion)
  • Any condition or situation that would, in the investigator's opinion, make it unlikely that the participant could adhere safely to the study protocol
  • Unwilling to abstain during the study from using smoking cessation aids other than those provided by the study
  • Unwilling to provide saliva or urine samples

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 14 and 19 years old?

Where in United States

  • Massachusetts General Hospital, Center for Addiction Medicine, 101 Merrimac Street, Suite 320, Boston, MA 02114Boston, United StatesContact: Julia Jashinski, MSWTaking people

About the trial

What the trial wants to find out

This study will test the hypothesis that the QuitVaping (QV) intervention and additional texting support will improve nicotine abstinence rates in adolescents as compared to Enhanced Usual Care (EUC: education about nicotine, vaping and addiction, advice to quit vaping, referral to TIQ texting support). Approximately 400 adolescents will be randomly assigned to one of two arms (1) QuitVaping intervention plus texting support to quit vaping and (2) EUC only.

The 2 groups in the trial

  • QuitVaping (QV)Treatment being tested

    Participants will: * Attend QuitVaping behavioral support sessions, completed via videoconference or in-person, once per week for 12 weeks * Be encouraged to sign up for This is Quitting (TIQ), a text message vaping cessation program for adolescents

    Treatment: QuitVaping and This is Quitting (TIQ)

  • Enhanced Usual Care (EUC)Existing treatment, for comparison

    Participants will: * Be encouraged to sign up for This is Quitting (TIQ), a text message vaping cessation program for adolescents * Attend no behavioral support sessions

    Treatment: This is Quitting (TIQ)

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Fit questions
Built from NCT06765291, who can take part
Record updated
7 July 2026